GB
Gregory Burshtein
Chief of Research & DevelopmentDr. Gregory Burshtein, PhD, is Chief of Research & Development of Entera Bio Ltd. from May 2024. Dr. Burshtein joined the Entera Bio Ltd. in September 2012 as Director of Pharmaceutical R&D. He has experience in the field of drug delivery, pharmacology and biopharmaceutics, with a primary focus on the challenging area of oral delivery of therapeutic peptides. He is the inventor of many patents and has presented and authored multiple publications in peer-reviewed journals related to oral delivery of peptides. Dr. Burshtein obtained his Ph.D. in Pharmaceutical Sciences, MSc in Clinical Pharmacy and B. Pharm degree from the Institute for Drug Research, Faculty of Medicine of the Hebrew University of Jerusalem.
Positions
- Company NameEntera Bio Ltd.Stock CodeENTXPositionChief of Research & DevelopmentColleagues
- MJMiranda J. ToledanoCEO & Director
- GJGeno J. GermanoIndependent Chairman
- HGHillel GalitzerChief Operating Officer
- DYDana Yaacov-GarbeliChief Financial Officer
- RBRachel B. WagmanChief Clinical Advisor
- FCFelicia CosmanChairman of Scientific Advisory Board & Chief Clinical Advisor (Endocrinology)
- HTHaya TaitelNon-Employee Independent Director
- SDSteven D. RubinIndependent Director
